Familial risk and familial survival in prostate cancer

World Journal of Urology

Volumn 30, Issue 2, 2012, Pages 143-148

  Hemminki, Kari ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Clinical counseling; Familial cancers; Genes; Survival

Indexed keywords

FACTUAL DATABASE; FAMILY; FATHER; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MORTALITY; NUCLEAR FAMILY; PROSTATE TUMOR; RETROSPECTIVE STUDY; REVIEW; RISK; SIBLING; SURVIVAL RATE; SWEDEN;

DATABASES, FACTUAL; FAMILY; FATHERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NUCLEAR FAMILY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK; SIBLINGS; SURVIVAL RATE; SWEDEN;

EID: 84859438311     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0801-1     Document Type: Review

References (24)

1. Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) How common is familial cancer. Ann Oncol 19: 163-167.
2. Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) Familial risks for cancer as the basis for evidence-based clinical referral and counseling. The Oncologist 13: 239-247.
3. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1607.
4. Bray F, Klint A, Gislum M et al (2010) Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 49: 644-654.
5. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348: 919-932.
6. Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22: 735-742.
7. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF et al (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1: e65.
8. Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ (2010) Genome-wide association studies in cancer-current and future directions. Carcinogenesis 31: 111-120.
9. Fletcher O, Houlston RS (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10: 353-361.
10. Hemminki K, Rawal R, Bermejo JL (2005) Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. Int J Cancer 113: 312-315.
11. Brandt A, Bermejo JL, Sundquist J, Hemminki K (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58: 275-280.
12. Brandt A, Bermejo JL, Sundquist J, Hemminki K (2009) Age at diagnosis and age at death in familial prostate cancer. Oncologist 14: 1209-1217.
13. Hemminki K, Sundquist J, Brandt A (2011) Familial mortality and familial incidence in cancer. J Clin Oncol 29: 712-718.
14. Hemminki K, Ji J, Försti A, Sundquist J, Lenner P (2008) Concordance of survival in family members with prostate cancer. J Clin Oncol 26: 1705-1709.
15. Risbridger GP, Davis ID, Birrell SN, Tilley WD (2010) Breast and prostate cancer: more similar than different. Nat Rev Cancer 10: 205-212.
16. Tryggvadottir L, Vidarsdottir L, Thorgeirsson T et al (2007) Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 99: 929-935.
17. Hemminki K, Forsti A, Chen B (2010) Breast and prostate cancer: familial associations. Nat Rev Cancer 10: 523.
18. Brandt A, Sundquist J, Hemminki K (2011) Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncol (in press).
19. Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91: 789-794.
20. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107: 797-803.
21. Thompson IM, Ankerst DP, Tangen CM (2010) Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma. J Natl Cancer Inst 102: 1299-1301.
22. Bratt O, Garmo H, Adolfsson J et al (2010) Effects of prostate-specific antigen testing on familial prostate cancer risk estimates. J Natl Cancer Inst 102: 1336-1343.
23. Lorenzo Bermejo J, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 97: 1575-1579.
24. Welch HG, Black WC (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102: 605-613.